Statistics for Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy
Total visits
views | |
---|---|
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy | 97 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
File Visits
views | |
---|---|
nihms-1025066.pdf | 110 |
java.util.UUID:cced49fb-f6f9-450e-8f64-a55571cd1075 | 60 |
java.util.UUID:b4233180-7562-4d7a-8ac8-c95a457bc721 | 22 |
java.util.UUID:1ed2442c-5750-4917-8dd5-4325d401117e | 19 |
Top country views
views | |
---|---|
United States | 73 |
Canada | 3 |
China | 2 |
Spain | 2 |
Sweden | 2 |
Germany | 1 |
Ireland | 1 |
Malaysia | 1 |
Russia | 1 |
Top city views
views | |
---|---|
Wilmington | 49 |
Fairfield | 8 |
Cambridge | 3 |
Houston | 3 |
San Francisco | 3 |
Toronto | 3 |
Beijing | 2 |
Madrid | 2 |
Stockholm | 2 |
Ann Arbor | 1 |
Dublin | 1 |
Gunzenhausen | 1 |
Jersey City | 1 |
Kansas City | 1 |
Kuala Lumpur | 1 |
Saint Petersburg | 1 |